DEA

The DEA Wants Teens To Become Anti-Weed Influencers For $25 A Pop
Trump Appoints Anti-Cannabis 'Just Say No' Drug Warrior As DEA Chief To 'Make America Safe Again'
Trump's Immigration Enforcement Raids Begin In Chicago: Gov. Pritzker Concerned Innocents Could Be Targeted
Trump Appoints Anti-Cannabis 'Just Say No' Drug Warrior As DEA Chief To 'Make America Safe Again'
Trump's Immigration Enforcement Raids Begin In Chicago: Gov. Pritzker Concerned Innocents Could Be Targeted
Elizabeth Warren To Elon Musk: Cut Unnecessary Federal Cannabis Enforcement And Save Billions
96% Of Cannabis Consumers Don't Trust DEA On Rescheduling Efforts: Poll

DEA Recent News

This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More
Cannabis news: DEA delays reform hearings, Florida renews legalization push and global markets expand.
DEA Judge Cancels Marijuana Rescheduling Hearing Amid 'Disturbing' Allegations Of Improper Conduct
Biden's proposal to ease restrictions on marijuana was delayed due to allegations of misconduct against the DEA.
The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And More
Cannabis news of the week: New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness.
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Cannabis Reform 2024: The Year Of All Talk And No Action
Biden didn't come tough on his pro-cannabis promise. Meanwhile, Congress seems to be "trapped in time," Rep. Earl Blumenauer says.
Trump Administration Could Ban Amazon's Top-Selling Routers Linked To Chinese Cyberattacks: Report
According to a Wall Street Journal report, U.S. authorities are investigating Chinese router manufacturer TP-Link as a possible threat to national security after multiple cyberattacks have been linked to the company's popular routers.
DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
DEA's cannabis rescheduling hearing begins January 21, 2025, as the industry raises concerns over process transparency and political influence.
Trump's DEA Drama: He Didn't Quit, I Fired Him — A Tale Of Pastors, Pandemic And Hurt Feelings
Florida's right-wing anti-maskers railed against Chronister during the Covid-19 pandemic. That may have cost him the DEA gig.
$13-Billion Drug War Funded By U.S. Taxpayers Fuels Violence In Developing Countries: New Report
U.S. taxpayer funding for drug war has led to human rights abuses and failed policies. Learn how foreign aid reinforces punitive drug control.
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Trump's DEA Pick Withdraws From Consideration, Will Keep Job As Florida Sheriff
Trump's DEA nominee, Florida sheriff Chad Chronister, has withdrawn from consideration after backlash. His office faced criticism over immigration policies.
Nebraska's Two-Front War On Cannabis
Nebraska: AG Mike Hilgers leads the fight against cannabis rescheduling, representing the state in the DEA hearing with prohibitionist SAM.
DEA LIVE Hearings On Marijuana Rescheduling, What To Expect
DEA's marijuana rescheduling hearings could reshape cannabis policy, easing research and tax rules while stopping short of full legalization.
Trump's Kash Patel FBI Pick And DEA Nominee Could Signal Shift In Drug Enforcement Priorities
Patel's vision for the FBI involves a sweeping restructuring, which includes dismantling its intelligence-gathering functions and purging its ranks of employees who are viewed as disloyal to Trump.
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.
Elon Musk, Vivek Ramaswamy: Here's An Agency You Might Want To Cut Back On And Save $40 Billion A Year
With Donald Trump's new DOGE initiative, it may be time to dismantle the DEA and legalize cannabis.
Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing
SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue's merits.
DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process
DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal
DEA Judge Blocks Researcher's Motion In Cannabis Rescheduling Case
DEA denies MedPharm's motion to join marijuana rescheduling hearing, raising concerns over exclusion and bias favoring prohibitionists.
DEA Banned From Random Airport Searches After Scathing Justice Department Report Uncovers Corruption
The DEA has been barred from conducting random searches of travelers' belongings at airports and transit hubs following a Justice Department investigation that exposed corrupt practices.
US Overdose Deaths Decline As Fentanyl Potency Weakens, Harm Reduction Expands
U.S. overdose deaths decline 14.5% in 2024, driven by weaker fentanyl potency, harm reduction efforts, and shifts in drug use behavior.
DEA Is Compromised, DOJ Should Replace It In Cannabis Rescheduling, Claims Joint Motion
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved